6-K
Smith & Nephew PLC (SNN)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the
Securities Exchange Act of 1934
November 10, 2025
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant’s name)
Building 5, Croxley Park, Hatters Lane
Watford, England, WD18 8YE
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ✔ Form 40-F __
SMITH & NEPHEW PLC
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
This announcement is made in accordance with the UK Market Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).
| Reason for the notification | ||||
|---|---|---|---|---|
| Initial<br>notification /Amendment | Initial<br>notification | |||
| Details of the issuer, emission allowance market participant,<br>auction platform, auctioneer or auction monitor | ||||
| Name | Smith<br>& Nephew plc | |||
| LEI | 213800ZTMDN8S67S1H61 | |||
| Details of the transaction(s): section to be repeated for (i) each<br>type of instrument; (ii) each type of transaction; (iii) each date;<br>and (iv) each place where transactions have been<br>conducted | ||||
| Description<br>of the financial instrument, type of instrument | Smith<br>& Nephew plc ordinary shares of USD 0.20 each | |||
| Identification<br>code | ISIN:<br>GB0009223206 | |||
| Nature<br>of the transaction | Purchase<br>of ordinary shares through the Company's Dividend Re-Investment<br>Plan following the 2025 interim dividend payment on 7 November<br>2025. | |||
| Date of<br>Transaction | 2025 -<br>11 - 07 | |||
| Place<br>of Transaction | London<br>Stock Exchange (XLON) | |||
| Name<br><br><br>(Position) | Director / PDMR | Price (£) | Volume | Aggregated information |
| --- | --- | --- | --- | --- |
| Scott<br>Schaffner<br><br><br>(President,<br>Sports Medicine) | PDMR | 12.4048 | 746.79305 | N/A<br>Single Transaction |
| Deepak<br>Nath<br><br><br>(Chief<br>Executive Officer) | Director | 12.4048 | 2624.43651 | N/A<br>Single Transaction |
| Rohit<br>Kashyap (President, Advanced Wound Management and Global Commercial<br>Operations) | PDMR | 12.4048 | 427.09066 | N/A<br>Single Transaction |
| Craig<br>Gaffin<br><br><br>(President,<br>Orthopaedics) | PDMR | 12.4048 | 197.25944 | N/A<br>Single Transaction |
| Mizanu<br>Kebede<br><br><br>(Chief<br>Quality & Regulatory Affairs Officer) | PDMR | 12.4048 | 4.1729 | N/A<br>Single Transaction |
| Paul<br>Connolly<br><br><br>(President,<br>Global Operations) | PDMR | 12.4048 | 394.41542 | N/A<br>Single Transaction |
Philip Horner
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
LEI: 213800ZTMDN8S67S1H61
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Smith & Nephew plc | ||
|---|---|---|
| (Registrant) | ||
| Date:<br>November 10, 2025 | By: | /s/<br>Helen Barraclough |
| Helen<br>Barraclough | ||
| Company<br>Secretary |